Product Code: SR112024A2131
The global clot management devices market size reached US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.8 Billion by 2032, exhibiting a growth rate (CAGR) of 4.8% during 2024-2032.
Clot management devices refer to the medical equipment that are used for the treatment of ailments such as pulmonary embolism (PE), arterial blood clots and deep vein thrombosis (DVT). Some of the commonly used clot management devices include catheter-directed thrombolysis (CDT) devices, embolectomy balloon catheters, percutaneous thrombectomy devices, neurovascular embolectomy devices and inferior vena cava filters (IVCFs). These devices aid in inhibiting the development of blood clots in the heart, brain, lungs and legs of the patient, thereby preventing the instances of potential ischemic strokes, severe leg pain and heart attacks.
Global Clot Management Devices Market Trends:
The increasing prevalence of cardiovascular diseases (CVDs), along with the rising geriatric population across the globe, is one of the key factors driving the growth of the market. Owing to the sedentary lifestyles and unhealthy dietary habits, a greater number of individuals are suffering from heart ailments, DVT and PE, thereby enhancing the demand for clot management devices. Furthermore, the growing preference for minimally invasive (MI) procedures by both patients and healthcare providers is also boosting the market growth. For instance, mechanical thrombectomy is an MI procedure in which the surgeon uses specialized equipment to remove the clot from the patient's artery through a small incision. Apart from this, the increasing instances of hip, knee and spinal injuries that require catheter-directed thrombolysis, have also created a positive impact on the market growth. Other factors, including various technological advancements, such as the development of next-generation thrombectomy devices, the continual launch of cost-effective devices, along with extensive research and development (R&D) activities in the field of medical sciences, are projected to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global clot management devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type and end-user.
Breakup by Product Type:
Neurovascular Embolectomy Devices
Embolectomy Balloon Catheters
Percutaneous Thrombectomy Devices
Mechanical Thrombectomy
Aspiration Thrombectomy
Percutaneous Mechanical Thrombectomy (PMT)
Catheter-Directed Thrombolysis Devices
Inferior Vena Cava Filters
Permanent
Retrievable
Breakup by End-User:
Hospitals
Diagnostic Centers and Specialty Clinics
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being AngioDynamics Inc., Argon Medical Devices Inc., Boston Scientific Corporation, DePuy Synthes Inc., Edwards Lifesciences Corporation, iVascular S.L.U., Lemaitre Vascular Inc., Medtronic Inc., Straub Medical AG, Stryker Corporation, Teleflex Incorporated, Vascular Solutions, etc.
Key Questions Answered in This Report:
- How has the global clot management devices market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What has been the impact of COVID-19 on the global clot management devices market?
- What is the breakup of the market based on the product type?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global clot management devices market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Clot Management Devices Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product Type
- 6.1 Neurovascular Embolectomy Devices
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Embolectomy Balloon Catheters
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Percutaneous Thrombectomy Devices
- 6.3.1 Market Trends
- 6.3.2 Major Types
- 6.3.2.1 Mechanical Thrombectomy
- 6.3.2.2 Aspiration Thrombectomy
- 6.3.2.3 Percutaneous Mechanical Thrombectomy (PMT)
- 6.3.3 Market Forecast
- 6.4 Catheter-Directed Thrombolysis Devices
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Inferior Vena Cava Filters
- 6.5.1 Market Trends
- 6.5.2 Major Types
- 6.5.2.1 Permanent
- 6.5.2.2 Retrievable
- 6.5.3 Market Forecast
7 Market Breakup by End-User
- 7.1 Hospitals
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Diagnostic Centers and Specialty Clinics
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Region
- 8.1 North America
- 8.1.1 United States
- 8.1.1.1 Market Trends
- 8.1.1.2 Market Forecast
- 8.1.2 Canada
- 8.1.2.1 Market Trends
- 8.1.2.2 Market Forecast
- 8.2 Asia Pacific
- 8.2.1 China
- 8.2.1.1 Market Trends
- 8.2.1.2 Market Forecast
- 8.2.2 Japan
- 8.2.2.1 Market Trends
- 8.2.2.2 Market Forecast
- 8.2.3 India
- 8.2.3.1 Market Trends
- 8.2.3.2 Market Forecast
- 8.2.4 South Korea
- 8.2.4.1 Market Trends
- 8.2.4.2 Market Forecast
- 8.2.5 Australia
- 8.2.5.1 Market Trends
- 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
- 8.2.6.1 Market Trends
- 8.2.6.2 Market Forecast
- 8.2.7 Others
- 8.2.7.1 Market Trends
- 8.2.7.2 Market Forecast
- 8.3 Europe
- 8.3.1 Germany
- 8.3.1.1 Market Trends
- 8.3.1.2 Market Forecast
- 8.3.2 France
- 8.3.2.1 Market Trends
- 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
- 8.3.3.1 Market Trends
- 8.3.3.2 Market Forecast
- 8.3.4 Italy
- 8.3.4.1 Market Trends
- 8.3.4.2 Market Forecast
- 8.3.5 Spain
- 8.3.5.1 Market Trends
- 8.3.5.2 Market Forecast
- 8.3.6 Russia
- 8.3.6.1 Market Trends
- 8.3.6.2 Market Forecast
- 8.3.7 Others
- 8.3.7.1 Market Trends
- 8.3.7.2 Market Forecast
- 8.4 Latin America
- 8.4.1 Brazil
- 8.4.1.1 Market Trends
- 8.4.1.2 Market Forecast
- 8.4.2 Mexico
- 8.4.2.1 Market Trends
- 8.4.2.2 Market Forecast
- 8.4.3 Others
- 8.4.3.1 Market Trends
- 8.4.3.2 Market Forecast
- 8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast
9 SWOT Analysis
- 9.1 Overview
- 9.2 Strengths
- 9.3 Weaknesses
- 9.4 Opportunities
- 9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
- 11.1 Overview
- 11.2 Bargaining Power of Buyers
- 11.3 Bargaining Power of Suppliers
- 11.4 Degree of Competition
- 11.5 Threat of New Entrants
- 11.6 Threat of Substitutes
12 Price Indicators
13 Competitive Landscape
- 13.1 Market Structure
- 13.2 Key Players
- 13.3 Profiles of Key Players
- 13.3.1 AngioDynamics Inc.
- 13.3.1.1 Company Overview
- 13.3.1.2 Product Portfolio
- 13.3.1.3 Financials
- 13.3.1.4 SWOT Analysis
- 13.3.2 Argon Medical Devices Inc.
- 13.3.2.1 Company Overview
- 13.3.2.2 Product Portfolio
- 13.3.3 Boston Scientific Corporation
- 13.3.3.1 Company Overview
- 13.3.3.2 Product Portfolio
- 13.3.3.3 Financials
- 13.3.3.4 SWOT Analysis
- 13.3.4 DePuy Synthes Inc.
- 13.3.4.1 Company Overview
- 13.3.4.2 Product Portfolio
- 13.3.5 Edwards Lifesciences Corporation
- 13.3.5.1 Company Overview
- 13.3.5.2 Product Portfolio
- 13.3.6 iVascular S.L.U.
- 13.3.6.1 Company Overview
- 13.3.6.2 Product Portfolio
- 13.3.6.3 Financials
- 13.3.7 Lemaitre Vascular Inc.
- 13.3.7.1 Company Overview
- 13.3.7.2 Product Portfolio
- 13.3.7.3 Financials
- 13.3.7.4 SWOT Analysis
- 13.3.8 Medtronic Inc.
- 13.3.8.1 Company Overview
- 13.3.8.2 Product Portfolio
- 13.3.9 Straub Medical AG
- 13.3.9.1 Company Overview
- 13.3.9.2 Product Portfolio
- 13.3.10 Stryker Corporation
- 13.3.10.1 Company Overview
- 13.3.10.2 Product Portfolio
- 13.3.10.3 Financials
- 13.3.10.4 SWOT Analysis
- 13.3.11 Teleflex Incorporated
- 13.3.11.1 Company Overview
- 13.3.11.2 Product Portfolio
- 13.3.11.3 Financials
- 13.3.11.4 SWOT Analysis
- 13.3.12 Vascular Solutions
- 13.3.12.1 Company Overview
- 13.3.12.2 Product Portfolio